The cost-effectiveness of particle therapy in non-small cell lung cancer: exploring decision uncertainty and areas for future research.
Grutters
Janneke P C
JP
Department of Radiation Oncology (MAASTRO), GROW-School for Oncology and Developmental Biology, Maastricht University Medical Centre, P.O. Box 1588, 6201 BN Maastricht, The Netherlands. janneke.grutters@maastro.nl
Pijls-Johannesma
Madelon
M
Ruysscher
Dirk De
DD
Peeters
Andrea
A
Reimoser
Stefan
S
Severens
Johan L
JL
Lambin
Philippe
P
Joore
Manuela A
MA
D002244:Carbon / Q000191:economics* / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000191:economics / Q000628:therapy*; D017321:Clinical Trials, Phase I as Topic; D003362:Cost-Benefit Analysis; D006801:Humans; D007477:Ions / Q000191:economics / Q000627:therapeutic use; D008175:Lung Neoplasms / Q000191:economics / Q000628:therapy*; D008390:Markov Chains; D061766:Proton Therapy; D019057:Quality-Adjusted Life Years; D016634:Radiosurgery / Q000191:economics; D011878:Radiotherapy / Q000191:economics
D007477:Ions; D002244:Carbon